✦ LIBER ✦

Cost Analysis of Screening According to ECCO Guidelines for Prevention of Opportunistic Infections in Infliximab-Treated IBD Patients

✍ Scribed by Metz, Andrew J. ;Elliott, Tim ;Hull, Bradley ;Duncan, Julie ;Sastrillo, Marlene ;Smith, Melissa A. ;Sanderson, Jeremy D. ;Irving, Peter M.

Book ID: 122329592
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 62 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63203-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for opportunistic infection

Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention

✍ C. Garcia-Vidal; S. Rodríguez-Fernández; S. Teijón; M. Esteve; M. Rodríguez-Carb 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 136 KB

T1316 Audit of Prevention of Opportunist

T1316 Audit of Prevention of Opportunistic Infections in Immunosuppressed Patients With IBD: How Close are We to ECCO Guidelines?

✍ Elliott, Tim; Duncan, Julie; Patel, Pritash; Smith, Melissa; Sanderson, Jeremy D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 94 KB

P351 Screening for opportunistic infecti

P351 Screening for opportunistic infection prior to initiating immunomodulator therapy in IBD patients – Practice in the North East of England

✍ Nair, S.; Hobday, D. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 183 KB